( en | de | ru )

 

Disambiguation

From post

копироватьудалитьдобавить публикацию в буфер
Selective inhibition of TNF-alpha or IL-1 beta does not affect E. coli-induced inflammation in human whole blood.

, , , , , , , и . Molecular Immunology, 47 (9): 1774--1782 (мая 2010)
DOI: 10.1016/j.molimm.2010.02.026

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

John D Howgate

D Böttger

D Zeppenfeld

D Zumkeller

D Riethmacher

 

Другие публикации лиц с тем же именем

High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of Obesity., , , , , , , и . Molecular cancer research : MCR, 14 (10): 953--965 (октября 2016)Complement deposits on ocular tissues adjacent to sites of inflammation., , , , , , и . Current Eye Research, 32 (11): 917--922 (ноября 2007)Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches., , , , и . Adv.Exp.Med.Biol., (2015)Progress and Trends in Complement Therapeutics., и . Adv.Exp.Med.Biol., 735 (Chapter 1): 1--22 (2013)Illuminating the latest advances in innate immunity on the island of the sun god., и . Expert review of clinical immunology, стр. 875--878. University of Louisville, Oral Health and Systemic Disease, Louisville, KY, USA., (ноября 2010)Complement in immune and inflammatory disorders: therapeutic interventions., и . Journal of immunology (Baltimore, Md. : 1950), 190 (8): 3839--3847 (апреля 2013)Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles., , , , , , , , и . 35 (11): 3688--3696 (апреля 2014)Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4., , и . Proceedings of the National Academy of Sciences, 114 (41): 10948--10953 (октября 2017)Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia., , , , , , и . Clinical immunology (Orlando, Fla.), (октября 2016)A structural basis for complement inhibition by Staphylococcus aureus., , , , , и . Nature Immunology, 8 (4): 430--437 (апреля 2007)